UPenn (Abramson Cancer Center, Pennsylvania Hospital) — Philadelphia, Pennsylvania

UPenn (Abramson Cancer Center, Pennsylvania Hospital) is a clinical research site located in Philadelphia, Pennsylvania, United States 19106.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

UPenn (Abramson Cancer Center, Pennsylvania Hospital) has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Soft Tissue Sarcoma.

Sponsors: Polaris Group.

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for UPenn (Abramson Cancer Center, Pennsylvania Hospital)?

UPenn (Abramson Cancer Center, Pennsylvania Hospital) has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has UPenn (Abramson Cancer Center, Pennsylvania Hospital) conducted?

UPenn (Abramson Cancer Center, Pennsylvania Hospital) has 1 clinical trials on record, with 1 currently active. Their work covers Soft Tissue Sarcoma.

Is UPenn (Abramson Cancer Center, Pennsylvania Hospital) accredited by Crixeo Health?

UPenn (Abramson Cancer Center, Pennsylvania Hospital) has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about UPenn (Abramson Cancer Center, Pennsylvania Hospital)?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.